Hjem › Juvenil myelomonocytisk leukemi › Michigan
Kliniske studier for Juvenil myelomonocytisk leukemi i Michigan
3 studier for Juvenil myelomonocytisk leukemi søker deltakere på steder i Michigan.
Byer i Michigan
Offisiell studietekst (engelsk)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- C.S. Mott Children's Hospital, Ann Arbor
RekruttererFase 1/2
1 Month – 21 Years · Alle kjønn · Oppdatert 4. sep. 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- C S Mott Children's Hospital, Ann Arbor
RekruttererFase 1
Alder 1 til 18 · Alle kjønn · Oppdatert 25. aug. 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- C S Mott Children's Hospital, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- og 2 flere
RekruttererFase 1/2
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.